Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07020637 · ClinicalTrials.gov registry record

Assessment of Stroke Volume in Shock Using Echocardiography Versus Bioreactive Impedance

A clinical trial of Critical Illness and Shock, sponsored by University of Nevada, Las Vegas.

Recruiting
Registry status
100
Enrollment target
1
Study location

NCT07020637 is a study of Critical Illness and Shock that is actively recruiting participants, run by University of Nevada, Las Vegas. The registered enrollment target is 100 participants, below the 3,137-participant average among 91 other Critical Illness trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07020637, a study of Critical Illness and Shock, is actively recruiting participants, sponsored by University of Nevada, Las Vegas.

RECRUITING
Registry status
100 participants
Enrollment target
1
Study location

Study Summary

This study aims to evaluate the correlation between stroke volume measurements obtained by transthoracic echocardiography and bioreactance-based noninvasive cardiac output monitoring. The primary objective is to assess the level of agreement between these two modalities in critically ill patients.

Conditions Studied

Interventions

  • DEVICE Cheetah NICOM

Study Locations (1)

Nevada

  • University Medical Center Southern Nevada - Las Vegas

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2024-10-19
Est. Completion 2026-09-01

Sponsor

University of Nevada, Las Vegas

52 total trials

What the Registry Record Tells You About NCT07020637

The ClinicalTrials.gov registry entry for NCT07020637 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,137-participant average among 91 other Critical Illness trials with a reported enrollment target (97% lower). The listed sponsor is University of Nevada, Las Vegas, which has 52 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Critical Illness appearing as the primary indexed condition, and to 1 intervention - of which Cheetah NICOM is the first listed.

NCT07020637 reports 1 study location spanning 1 distinct geographic area - top geographies include Nevada.

Frequently Asked Questions

What is clinical trial NCT07020637 about?

NCT07020637 is a clinical study titled "Assessment of Stroke Volume in Shock Using Echocardiography Versus Bioreactive Impedance". This study aims to evaluate the correlation between stroke volume measurements obtained by transthoracic echocardiography and bioreactance-based noninvasive cardiac output monitoring. The primary objective is to assess the level of agreement between these two modalities in critically ill patients.

What is the current status of trial NCT07020637?

This trial is currently recruiting. The enrollment target is 100 participants. The study started on 2024-10-19. Estimated completion is 2026-09-01.

What conditions does trial NCT07020637 study?

This clinical trial studies the following conditions: Critical Illness, Shock.

What interventions are being tested in trial NCT07020637?

The interventions under investigation include: Cheetah NICOM (DEVICE).

Who is sponsoring clinical trial NCT07020637?

This trial is sponsored by University of Nevada, Las Vegas, which has 52 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07020637 being conducted?

This trial has 1 study location across Nevada. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Critical Illness

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.